|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1995-4-27
|
|
pubmed:abstractText |
Interferon is considered to be an important curative agent for dermatologic diseases. We report the follow-up experience of patients with basal cell or squamous cell carcinomas treated with human natural leukocyte interferon (HNLI).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0011-9059
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
N
|
|
pubmed:pagination |
58-60
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7896491-Adult,
pubmed-meshheading:7896491-Aged,
pubmed-meshheading:7896491-Aged, 80 and over,
pubmed-meshheading:7896491-Carcinoma, Basal Cell,
pubmed-meshheading:7896491-Carcinoma, Squamous Cell,
pubmed-meshheading:7896491-Facial Neoplasms,
pubmed-meshheading:7896491-Female,
pubmed-meshheading:7896491-Follow-Up Studies,
pubmed-meshheading:7896491-Humans,
pubmed-meshheading:7896491-Interferon Type I,
pubmed-meshheading:7896491-Interferon-alpha,
pubmed-meshheading:7896491-Male,
pubmed-meshheading:7896491-Middle Aged,
pubmed-meshheading:7896491-Neoplasm Recurrence, Local,
pubmed-meshheading:7896491-Recombinant Proteins,
pubmed-meshheading:7896491-Remission Induction,
pubmed-meshheading:7896491-Skin Neoplasms
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
Interferon reduces recurrences of basal cell and squamous cell cancers.
|
|
pubmed:affiliation |
Department of Medicine, Croatian Academy of Sciences and Arts, Zagreb.
|
|
pubmed:publicationType |
Journal Article
|
